Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm
Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
Review article: dose optimisation of infliximab for acute severe ulcerative colitis
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation
Serum alkylresorcinols as biomarkers of dietary gluten exposure in coeliac disease
Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor- α medications among patients with inflammatory bowel diseases
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease
Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study
Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt
Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection
Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection
The albumin–bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development
Expert clinical management of autoimmune hepatitis in the real world
The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210
Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience
Editorial: improving in-hospital management of decompensated cirrhosis by a ‘care bundle’ – hope, frustration, and lessons to learn
Editorial: improving in-hospital management of decompensated cirrhosis by a ‘care bundle’ – hope, frustration and lessons to learn. Authors' reply
Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer?
Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer? Authors' reply
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors' reply
Letter: causes of fatigue in inflammatory bowel disease remain uncertain
Letter: causes of fatigue in inflammatory bowel disease remain uncertain – authors' reply
Letter: more studies are needed to elucidate any association between Helicobacter pylori infection and Barrett's metaplasia
Letter: can transient elastography and body mass index predict fibrosis regression in HBV patients on long-term nucleoside therapy?